Company Overview - Tectonic Therapeutic, Inc. is a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs) [4] - The company leverages its proprietary GEODe™ technology platform to develop biologic medicines aimed at overcoming challenges in GPCR-targeted drug discovery [4] - Tectonic targets areas of significant unmet medical need, where therapeutic options are limited or nonexistent, to improve patient quality of life [4] Upcoming Event - Alise Reicin, MD, President and Chief Executive Officer of Tectonic, will present at the Piper Sandler 36th Annual Healthcare Conference in New York from December 3-5, 2024 [1] - The presentation is scheduled for December 3rd, 2024, at 12:30 PM ET [2] - A live webcast of the presentation will be available on Tectonic's website, with a replay accessible for approximately 90 days post-conference [3]
Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference